HSP90 Inhibitor, 17-DMAG, Alone and in Combination with Lapatinib Attenuates Acquired Lapatinib-Resistance in ER-positive, HER2-Overexpressing Breast Cancer Cell Line.

Autor: Lee, Hye Jin1 (AUTHOR) lhj5727@korea.ac.kr, Shin, Seungho2 (AUTHOR) sshhere@korea.ac.kr, Kang, Jinho1 (AUTHOR) kang701@korea.ac.kr, Han, Ki-Cheol3 (AUTHOR) biolord@kist.re.kr, Kim, Yeul Hong1 (AUTHOR) yhk0215@korea.ac.kr, Bae, Jeoung-Won2 (AUTHOR) kujwbae@korea.ac.kr, Park, Kyong Hwa1 (AUTHOR) khpark@korea.ac.kr
Zdroj: Cancers. Sep2020, Vol. 12 Issue 9, p2630. 1p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje